Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.
暂无分享,去创建一个
W Chen | J. Yewdell | J. Bennink | W. Chen | L. C. Antón | J W Yewdell | J R Bennink | L C Antón | Weisan Chen | Luis C. Antón | Jonathan W. Yewdell | J. Yewdell
[1] R M Zinkernagel,et al. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. , 1979, Advances in immunology.
[2] D. Busch,et al. Coordinate regulation of complex T cell populations responding to bacterial infection. , 1998, Immunity.
[3] Alessandro Sette,et al. Conserved T Cell Receptor Repertoire in Primary and Memory CD8 T Cell Responses to an Acute Viral Infection , 1998, The Journal of experimental medicine.
[4] A. Miller,et al. Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.
[5] R. Anderson,et al. Antigen processing in vivo and the elicitation of primary CTL responses. , 1995, Journal of immunology.
[6] J. Yewdell,et al. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.
[7] J. Yewdell,et al. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. , 1997, Journal of immunology.
[8] S. L. Silins,et al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen , 1995, The Journal of experimental medicine.
[9] W. Deppert,et al. Relationship among immunodominance of single CD8+ T cell epitopes, virus load, and kinetics of primary antiviral CTL response. , 1998, Journal of immunology.
[10] A. McMichael,et al. A New Look at T Cells , 1998, The Journal of experimental medicine.
[11] F. Carbone,et al. Evidence for cooperation between TCR V region and junctional sequences in determining a dominant cytotoxic T lymphocyte response to herpes simplex virus glycoprotein B. , 1997, International immunology.
[12] C. Heusser,et al. Detection of intracellular cytokines by flow cytometry. , 1993, Journal of immunological methods.
[13] J. Yewdell,et al. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. , 1997, Journal of immunology.
[14] S. H. van der Burg,et al. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. , 1996, Journal of immunology.
[15] R. Ahmed,et al. T cell memory. Long-term persistence of virus-specific cytotoxic T cells , 1989, The Journal of experimental medicine.
[16] J. Bennink,et al. The response to H-2-different virus-infected cells is mediated by long-lived T lymphocytes and is diminished by prior virus priming in a syngeneic environment. , 1981, Cellular immunology.
[17] J. Altman,et al. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. , 1998, Immunity.
[18] Philippe Bousso,et al. The Composition of a Primary T Cell Response Is Largely Determined by the Timing of Recruitment of Individual T Cell Clones , 1999, The Journal of experimental medicine.
[19] Rachael Keating,et al. The Cytotoxic T-Cell Response to Herpes Simplex Virus Type 1 Infection of C57BL/6 Mice Is Almost Entirely Directed against a Single Immunodominant Determinant , 1999, Journal of Virology.
[20] J. Yewdell,et al. Modification of Cysteine Residues In Vitro and In Vivo Affects the Immunogenicity and Antigenicity of Major Histocompatibility Complex Class I–restricted Viral Determinants , 1999, The Journal of experimental medicine.
[21] T. Hogg,et al. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection. , 1997, Journal of immunology.
[22] H. Rammensee,et al. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast , 1991, The Journal of experimental medicine.